63 related articles for article (PubMed ID: 11513192)
1. Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C.
Naeem M; Bacon BR; Mistry B; Britton RS; Di Bisceglie AM
Am J Gastroenterol; 2001 Aug; 96(8):2468-72. PubMed ID: 11513192
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
3. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment.
Gopal K; Johnson TC; Gopal S; Walfish A; Bang CT; Suwandhi P; Pena-Sahdala HN; Clain DJ; Bodenheimer HC; Min AD
Hepatology; 2006 Aug; 44(2):335-40. PubMed ID: 16871569
[TBL] [Abstract][Full Text] [Related]
4. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
Fujita N; Kaito M; Kai M; Sugimoto R; Tanaka H; Horiike S; Konishi M; Iwasa M; Watanabe S; Adachi Y
J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
[TBL] [Abstract][Full Text] [Related]
5. Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy.
Hamamoto S; Uchida Y; Wada T; Moritani M; Sato S; Hamamoto N; Ishihara S; Watanabe M; Kinoshita Y
J Gastroenterol Hepatol; 2005 Feb; 20(2):204-8. PubMed ID: 15683422
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin in the treatment of hepatitis C.
Abonyi ME; Lakatos PL
Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
[TBL] [Abstract][Full Text] [Related]
7. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
9. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
[TBL] [Abstract][Full Text] [Related]
10. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
[TBL] [Abstract][Full Text] [Related]
11. Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
Pellicano R; Puglisi G; Ciancio A; Balzola F; Saracco G; Ciccone G; Baldi I; Abate ML; Smedile A; Rizzetto M
J Med Virol; 2008 Apr; 80(4):628-31. PubMed ID: 18297716
[TBL] [Abstract][Full Text] [Related]
12. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
13. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
Stintzing S; Schmitt C; Ocker M; Ganslmayer M; Zopf S; Gahr S; Hahn EG; Herold C
Hepatogastroenterology; 2009; 56(90):462-5. PubMed ID: 19579621
[TBL] [Abstract][Full Text] [Related]
14. [Changes of lipid metabolism in patients with chronic viral hepatitis treated with interferon alpha].
Zejc-Bajsarowicz M; Cieśla A; Mach T; Janas-Skulina U; Warunek W; Zyrkowska-Bieda T
Przegl Lek; 2005; 62(4):214-7. PubMed ID: 16229237
[TBL] [Abstract][Full Text] [Related]
15. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
Di Bisceglie AM; Bonkovsky HL; Chopra S; Flamm S; Reddy RK; Grace N; Killenberg P; Hunt C; Tamburro C; Tavill AS; Ferguson R; Krawitt E; Banner B; Bacon BR
Hepatology; 2000 Jul; 32(1):135-8. PubMed ID: 10869301
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha.
Fernández-Miranda C; Castellano G; Guijarro C; Fernández I; Schöebel N; Larumbe S; Gómez-Izquierdo T; del Palacio A
Am J Gastroenterol; 1998 Oct; 93(10):1901-4. PubMed ID: 9772052
[TBL] [Abstract][Full Text] [Related]
17. Influence of baseline values. I: Effects on plasma total cholesterol and triglyceride levels during doxazosin treatment for hypertension.
Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
Int J Clin Pharmacol Res; 1998; 18(4):159-63. PubMed ID: 10052025
[TBL] [Abstract][Full Text] [Related]
18. Serum cholesterol and low-density lipoprotein cholesterol levels as predictors of response to interferon therapy for chronic hepatitis C.
Minuk GY; Weinstein S; Kaita KD
Ann Intern Med; 2000 May; 132(9):761-2. PubMed ID: 10787379
[No Abstract] [Full Text] [Related]
19. Effect of interferon therapy on heart rate and sympathetic nervous system.
Yamamoto T; Tsuchihashi T; Hayashi J; Kashiwagi S
Fukuoka Igaku Zasshi; 1998 Jul; 89(7):207-15. PubMed ID: 9745188
[TBL] [Abstract][Full Text] [Related]
20. EFFECT OF STANDARD INTERFERON AND RIBAVIRIN ON LEUKOCYTECOUNT.
Jadoon SA; Ahmed A; Jehangiri AU; Ahmad N
J Ayub Med Coll Abbottabad; 2015; 27(2):364-6. PubMed ID: 26411117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
